Table 3.
Discharge/Follow‐Up Characteristics
Na | Nonskiers N=4881 | Skiers N=1083 | P Valueb | |
---|---|---|---|---|
Severity of stroke | ||||
Mobility | 5231 | <0.001 | ||
Deceased | 351 (8.3) | 73 (7.5) | ||
No assistance | 3271 (76.9) | 819 (83.8) | ||
With assistance indoors | 310 (7.3) | 44 (4.5) | ||
With assistancec | 322 (7.6) | 41 (4.2) | ||
Need assistance for toilet visits | 4812 | 385 (9.9) | 51 (5.6) | <0.001 |
Dressing with assistance | 4809 | 470 (12.0) | 67 (7.4) | <0.001 |
Dependent | 4066 | 0.001 | ||
Partially | 1132 (34.3) | 229 (29.9) | ||
Totally | 292 (8.9) | 49 (6.4) | ||
Speaking problems | 2356 | 512 (27.1) | 111 (23.8) | 0.15 |
Depressive mode | 4028 | <0.001 | ||
Almost never | 1438 (44.1) | 418 (54.4) | ||
Sometimes | 1477 (43.3) | 306 (39.8) | ||
General health | 3983 | <0.001 | ||
Poor | 67 (2.1) | 9 (1.2) | ||
Bad | 427 (13.2) | 48 (6.3) | ||
Good | 2181 (67.6) | 499 (65.8) | ||
Very good | 550 (17.1) | 202 (26.6) | ||
Smoking | 3474 | 398 (14.2) | 24 (3.5) | <0.001 |
Discharge/follow‐up treatments | ||||
Hypertension treatment | 3394 | 1989 (72.8) | 383 (57.9) | <0.001 |
Warfarin | 5003 | 411 (10.0) | 132 (14.5) | <0.001 |
Thrombolysis | 5137 | 192 (4.6) | 60 (6.4) | 0.017 |
Calcium antagonists | 4127 | 467 (23.2) | 130 (16.8) | <0.001 |
ACE‐inhibitors | 2767 | 931 (41.3) | 182 (35.4) | <0.014 |
Angiotensin II‐blockers | 2766 | 263 (11.7) | 42 (8.2) | <0.022 |
Diuretics | 4127 | 740 (22.1) | 118 (15.2) | <0.001 |
Statins | 4127 | 1958 (58.4) | 438 (56.5) | 0.33 |
Aspirin | 5015 | 2611 (63.6) | 554 (60.9) | 0.13 |
Clopidogrel | 4128 | 213 (6.4) | 48 (6.2) | 0.87 |
Aspirin+clopidogrel | 4131 | 136 (4.1) | 36 (4.6) | 0.46 |
Dipyridamole | 4138 | 491 (14.6) | 103 (13.3) | 0.33 |
Numbers represent frequencies with percentages in parentheses. Note that the denominator is different between variables due to partial missing of data. ACE indicates angiotensin‐converting enzyme; Nonskiers, population‐based controls with the same age, sex, and same county of residence; Skiers, the participants in the Vasaloppet.
Number of nonmissing observations.
Pearson χ2 test.
From 2001.